Progressive Care Inc (RXMD)

[stockforce]

WALL STREET FORUM PRESENTATION PDF FILE IS HERE

They updated the presentation PR and added a link to the whole presentation slides:

https://progressivecareus.com/investor-presentation-march-2018/

Highlights:









Shital Mars: I think I said it before and I can’t express it more strenuously than we are at the beginning. We are at the cusp of something great. From 2015, we’ve eliminated all of our aged debt. We are current. We have a great funding partner in Chicago Ventures. We are working on mergers and acquisitions. Our next goal, we’re on OTCQB and we want to become a company worthy of being on NASDAQ and that’s what we’re working towards. And we think that we are delivering value to our shareholders, we are growing, and more importantly, we’re a business that you can be proud of. We help patients, we’re a community pillar, and we think that more people should get involved and look at a company like ours and see what we can do and now is just the beginning.
Wall Street Analyzer interview - March 1, 2018
http://wallstreetanalyzer.com/2018/03/01/progressive-care-inc-otcqb-rxmd-ceo-shital-mars/


Uptick Newswire: Are you guys thinking about moving up to the NASDAQ?

Shital Mars: "Yes. So the ultimate goal has always been to become fully SEC reporting and list on NASDAQ. We think that is the right place and right path for us to go. And we think healthcare is ripe for that change and we think there’s a lot of competition and opportunity in the marketplace for a company like ours to create something special and unique and worthy of being on NASDAQ. We also know that we want to have the right vehicle for it. So it’s not something we want to do just as we are today. We want to evolve into that NASDAQ worthy company, and we are putting all the staff in place, all the factors, all the personnel and resources in place right now to get us to there as our end goal."
Uptick Newswire's interview on Feb 1, 2018:
https://upticknewswire.com/featured-interview-ceo-shital-mars-of-progressive-care-inc-otcqb-rxmd/


Uptick Newswire: You and I talked before about you guys uplisting to the NASDAQ. I ‘d like for you to respond on that.
Shital Mars: So to answer your question of going to NASDAQ. It has always been a goal of ours…… I think in order to do that, we have to make right acquisition, we have to have right partner, we have to have right capital. And I think we can do that. We are executing now. We built the great foundation of the last two years. We are executing now on getting that investor base, getting that capital, and getting those acquisitions under our belt. And then you are gonna see us on NASDAQ as a 75 million dollar revenue company worthy of being there, and then people will be really proud to see how far we have come once we are there……
Uptick Newswire Interview - 3/12/2018
https://upticknewswire.com/featured-interview-ceo-shital-mars-of-progressive-care-inc-otcqb-rxmd-2/

"We have been rapidly gaining ground in Palm Beach County and this is the missing piece to lasting success in the area. After an exhaustive search, we think that this acquisition will be just the beginning of an aggressive expansion agenda that allows the Company to reach thousands of new doctors and patients who will benefit greatly from the PharmCo pharmacy model.”
https://www.otcmarkets.com/stock/RXMD/news/UPDATE----Progressive-Care-Executes-Letter-of-Intent-to-Purchase-a-Pharmacy-in-Palm-Beach-County?id=185877

Ms. Mars confirmed again that the new acquisition is in West Palm Beach city and the deal will be closed in Q2. The new pharmacy's biggest customers are long term care facilities. The company is currently in active negotiations with a second pharmacy as an acquisition target.
They are considering an acquisition or forming joint venture with one or more CBD suppliers, which will be the easiest way to commercialize their CBD products. They are also considering developing their own products independently. The company is meeting with Law Firms in preparation for a future uplist to the NASDAQ. They will fully file with SEC as part of the preparation work asap.
Investors Conference Call - March 22, 2018
http://progressivecareus.com/2017-audited-financials/

2013 net revenue: $9.33M
2014 net revenue: $11.27M
2015 net revenue: $13.64M
2016 net revenue: $18.32M
2017 NET REVENUE: $20.1M
“Filing our second year of audited financial statements 10 days early has a profound significance for me personally,” stated S. Parikh Mars, CEO. “In all the years, I have worked with Progressive Care both inside and out, we were not able to accomplish this goal until now. I could not be prouder of the accounting team we have put together this year and a staff that knows how to do things right every day. I hope that we are delivering the transparency our shareholders expect and the results that motivate them to keep believing in this company.”
https://www.otcmarkets.com/stock/RXMD/news/Progressive-Care-Releases-Audited-2017-Annual-Report?id=186874

UPDATED INVESTOR PRESENTATION BY MS. MARS - MARCH 27, 2018:
https://www.youtube.com/watch?v=Dim6GNLKzp0

DD by ndwd42
$RXMD UPCOMING CATALYSTS / NEWS

Acquisition finalization: With the latest announcement of the company's intent to purchase a pharmacy (LOI) in Palm Beach County, we will see additional details around this purchase and what it means on the revenue side.

March Numbers: Week of April 12th or 19th - should be record revenues again with possibly our second 2M+ month.

Additional technology partnerships / contracts: Progressive care is both a healthcare services and technology company. Expect additional PRs and contracts stating new revenues streams

Institutional buying: We've had what looks to be institutional buying recently and I would venture to guess we will receive more news about institutions covering us and major investments after we have our two years of audited financials in April.

Institutional stock coverage: Shital has made it clear that she'd like to have coverage of the stock by institutional analysts. We are seeing more and more signs of this and will hear more about it soon IMO.

Online Pharmacy / e-Commerce: With the news of Bitcoin and Amazon looking to get into the pharmacy space, expect additional news on RXMD about becoming a major online pharmacy.

CBD / MJ / HEMP: One of the latest major developments. Additional news about CBD and MJ will most likely be coming out in the next couple of months. They already stated they will have in-house compounding and R&D! This will boost sales big time as customers would like to see alternatives to addictive pain pills.

Tech / Tele-Pharm news: With the latest development of this being a tech play, we should hear more about their plan for tele-Pharmco and also we should hear from our NASDAQ independent board member on the latest developments.

New 340B contracts: Over the next month or two we will most likely hear about new 340B contracts from multiple partners

New Long term care facility relationships: The company continues to be active in the community with doctors, patients and long term facilities. Expect additional partnerships on this front.

Achieve accreditation for non-sterile compounding: One the company's stated goals for 2018 is receiving accreditation for non-sterile compounding. This will actually allow them to make more money with more of a backing.

Traditional financing: Expect news of traditional financing over the coming year.

Opening more Pharmco Pharmacy Resource Centers in retirement and long term care communities: Another 2018 goal of the company. They will announce more resource centers to again strengthen their relationships in the community.

More out of state licenses: They've already obtained 15 state licenses where they can do business and planning to expand to more states. We may hear more about these revenue streams as they add to the bottom line.

Purdue sales rep team: We should be hearing more about the Purdue pharma sales force to join the team for conducting out of state sales

Aggressive expansion / M&A: We should be seeing additional PBM contracts related to their recent acquisition. I also believe we will hear more about additional acquisitions and other partnerships.

NASDAQ uplisting: With traditional financing, 2 locations and a much higher PPS, I expect to start to hear more about the company's plan to uplist to NASDAQ.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=139614734

The only projection shareholders really care about is how much revenue this company is gonna make in 2018 after 1 or 2 or more acquisitions, how much more money they are gonna make once their CBD products start selling this year? How high the stock price will go once institutions start investing? How many more acquisition deals they will sign in 2019? How soon they will uplist to NASDAQ, which probably will be even this year. The management team has been very consistent and determined through all these years, and they are very results-driven. All these hard work have led to the $20M company that we are trading today. This is a stock that's bound to uplist to the NASDAQ. No fluffy stuff, only solid financials and fast expansions with great leaders. More exciting achievements are being made right now. Great future ahead.

Closing Remarks by the CEO

"The strength of Progressive Care has always been in the hands of its employees and its shareholders. Without the loyalty and dedication of both, this Company would not be where it is today. We have thrived because of the unyielding support in the face of immense challenges and we know that we must never waver in our desire to always earn the trust that has been bestowed upon us. Thank you to all who believe in us and we look forward to delivering another phenomenal year."

https://www.otcmarkets.com/stock/RXMD/news/Progressive-Care-Releases-Open-Letter-to-Shareholders?id=180513